borderline significantP <0.05
Overall bleeding complications were more frequently observed when antithrombotic drugs were used (borderline significant=0.051), in particular, in patients who used double antiplatelet therapy ( P <0.05).
Overall bleeding complications were more frequently observed when antithrombotic drugs were used (borderline significant=0.051), in particular, in patients who used double antiplatelet therapy ( P <0.05).